Pfizer’s phase 3 studies of novel antibiotic combination offer new hope for patients with multidrug-resistant infections and treatment options
AstraZeneca receives CDSCO approval for Tremelimumab combination in India
Merck partners with California-based research group to study catalysis innovation through machine learning
Philips and Masimo introduce advanced monitoring capabilities to Philips high acuity patient monitors
Lonza acquires biotech firm Synaffix
Subscribe To Our Newsletter & Stay Updated